The U.S. military has lessened its stringent health requirements to cope with lagging recruitment numbers, contributing to an ...

Obesity is not only a lifestyle issue but a major risk factor for cancer in men. With rising obesity rates in India, it’s ...

Discover expert tips from an obesity medicine doctor on effective and sustainable ways to approach weight loss for type 2 ...

India has officially approved and launched Mounjaro (tirzepatide), a groundbreaking injectable medication for the treatment of Type 2 diabetes and obesity. Developed by Eli Lilly and Company, the drug ...

Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...

Semaglutides, which are used to treat type 2 diabetes and obesity, were the most-sold medication in Finland last year, ...

Eli Lilly’s LLY key top-line drivers are its GLP-1 medicines, Mounjaro for type II diabetes and Zepbound for obesity. Both ...

In a bold move to address the growing epidemic of lifestyle diseases in India, Redial Clinic has launched a nationwide initiative focused on reversing type 2 diabetes, hypertension, and obesity ...

Indian contract drug manufacturer OneSource Specialty Pharma expects strong growth in its order book over the next three years, driven by the global boom in weight-loss drugs, its top executive said ...

(The Center Square) - Sen. Ruben Gallego, D-Arizona, announced his support for a bill aimed at helping America’s obesity ...

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a ...